With the biopharmaceutical world still buzzing from the latest data presented at the American Society of Hematology meeting, we sat down with industry expert Ivan Kairatov to unpack the results that have sent one company's stock soaring. At the center of the discussion is TERN-701, an experimental
Imagine a world where a single shot at birth could shield a child from a devastating liver disease, yet the decision to administer it hangs in a delicate balance of science, public opinion, and political will. In the United States, the hepatitis B vaccine, a cornerstone of infant health for over
Allow me to introduce Ivan Kairatov, a seasoned biopharma expert whose extensive background in technology and innovation has positioned him at the forefront of groundbreaking developments in genetic medicine. With years of experience in research and development, Ivan has been closely following the
Imagine a world where the most abundant immune cells in the human body, crucial for fighting infections, remain a mysterious black box to scientists and medical professionals. For too long, neutrophils—those rapid-response warriors of the immune system—have been just that, with their complex
Diving into the mysteries of the human brain, I’m thrilled to sit down with a leading expert in neuroscience whose groundbreaking work has reshaped our understanding of brain plasticity and adult neurogenesis. As a full professor at the University of Amsterdam and head of the Brain Plasticity
Today, we’re diving into the groundbreaking world of blood cancer research with Dr. Ivan Kairatov, a renowned biopharma expert whose deep knowledge of technology and innovation is driving transformative change in the fight against follicular lymphoma. As a key figure in the ERADICATE Follicular
Imagine a silent invader within the body, cunningly crafting escape routes to spread its destruction far beyond its origin. Breast cancer, one of the most prevalent cancers globally, operates with such stealth, manipulating the lymphatic system to fuel its deadly journey. This roundup dives deep
Diving into the intricate world of cancer biology, we’re thrilled to speak with Ivan Kairatov, a renowned biopharma expert with a profound background in research and development. With a sharp focus on technological innovation in the industry, Ivan has been at the forefront of uncovering how
Imagine a simple stroll down the hallway revealing the future of a patient’s recovery from major hip surgery—sounds almost too straightforward to be true, doesn’t it? Yet, a pioneering study from Kyushu University in Japan has uncovered that the speed at which someone walks before undergoing total
Rising failure rates for single-mechanism therapies in heterogeneous solid tumors have pushed oncology beyond single-target tinkering and into platform-centric thinking that prizes modularity, combinability, and consistent manufacturability across programs. In this shift, antibody-drug conjugates
